Literature DB >> 12451203

Incidence and outcome of mild cognitive impairment in a population-based prospective cohort.

S Larrieu1, L Letenneur, J M Orgogozo, C Fabrigoule, H Amieva, N Le Carret, P Barberger-Gateau, J F Dartigues.   

Abstract

OBJECTIVE: To estimate the age-specific incidence rate of mild cognitive impairment (MCI) according to sex and educational level and to explore the course of MCI, particularly its progression to AD, in a population-based cohort.
METHODS: A community-based cohort of nondemented elderly people (Personnes Agées QUID [PAQUID]) was followed longitudinally for 5 years. MCI was defined as memory complaints with objective memory impairment, without dementia, impairment of general cognitive functioning, or disability in activities of daily living. Incidence rates were calculated using the person-years method. A descriptive analysis at the different follow-up times was performed to study the course of MCI.
RESULTS: At baseline, there were 58 prevalent cases of MCI (2.8% of the sample). During a 5-year follow-up, 40 incident cases of MCI occurred in 1,265 subjects at risk. The global incidence rate of MCI was 9.9/1,000 person-years. MCI was a good predictor of AD with an annual conversion rate of 8.3% and a good specificity, but it was very unstable over time: Within 2 to 3 years, only 6% of the subjects continued to have MCI, whereas >40% reverted to normal.
CONCLUSIONS: Conventionally defined MCI has reasonable predictive value and specificity for AD. However, MCI was very unstable across time in this study. Furthermore, the definition of MCI seems to be too restrictive and should probably be extended to other categories of individuals also at high risk of developing AD.

Entities:  

Mesh:

Year:  2002        PMID: 12451203     DOI: 10.1212/01.wnl.0000034176.07159.f8

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  160 in total

1.  Incidence and risk factors for cognitive impairment no dementia and mild cognitive impairment in African Americans.

Authors:  Frederick W Unverzagt; Adesola Ogunniyi; Vanessa Taler; Sujuan Gao; Kathleen A Lane; Olusegun Baiyewu; Oye Gureje; Valerie Smith-Gamble; Ann Hake; Hugh C Hendrie; Kathleen S Hall
Journal:  Alzheimer Dis Assoc Disord       Date:  2011 Jan-Mar       Impact factor: 2.703

Review 2.  Amyloid imaging as a biomarker for cerebral β-amyloidosis and risk prediction for Alzheimer dementia.

Authors:  William E Klunk
Journal:  Neurobiol Aging       Date:  2011-12       Impact factor: 4.673

3.  Incidence of dementia in oldest-old with amnestic MCI and other cognitive impairments.

Authors:  Carrie B Peltz; María M Corrada; Daniel J Berlau; Claudia H Kawas
Journal:  Neurology       Date:  2011-11-09       Impact factor: 9.910

4.  A two-year follow-up of cognitive deficits and brain perfusion in mild cognitive impairment and mild Alzheimer's disease.

Authors:  Montserrat Alegret; Gemma Cuberas-Borrós; Georgina Vinyes-Junqué; Ana Espinosa; Sergi Valero; Isabel Hernández; Isabel Roca; Agustín Ruíz; Maitée Rosende-Roca; Ana Mauleón; James T Becker; Joan Castell-Conesa; Lluís Tárraga; Mercè Boada
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

5.  Fornix integrity and hippocampal volume predict memory decline and progression to Alzheimer's disease.

Authors:  Michelle M Mielke; Ozioma C Okonkwo; Kenichi Oishi; Susumu Mori; Sarah Tighe; Michael I Miller; Can Ceritoglu; Timothy Brown; Marilyn Albert; Constantine G Lyketsos
Journal:  Alzheimers Dement       Date:  2012       Impact factor: 21.566

Review 6.  Quantitative structural MRI for early detection of Alzheimer's disease.

Authors:  Linda K McEvoy; James B Brewer
Journal:  Expert Rev Neurother       Date:  2010-11       Impact factor: 4.618

7.  Prevalence and incidence rates of dementia and cognitive impairment no dementia in the Mexican population: data from the Mexican Health and Aging Study.

Authors:  Silvia Mejia-Arango; Luis Miguel Gutierrez
Journal:  J Aging Health       Date:  2011-10

8.  Cognitive impairment in lacunar strokes: the SPS3 trial.

Authors:  Claudia Jacova; Lesly A Pearce; Raymond Costello; Leslie A McClure; Stephen L Holliday; Robert G Hart; Oscar R Benavente
Journal:  Ann Neurol       Date:  2012-09       Impact factor: 10.422

9.  Cerebral perfusion correlates of conversion to Alzheimer's disease in amnestic mild cognitive impairment.

Authors:  A Caroli; C Testa; C Geroldi; F Nobili; L R Barnden; U P Guerra; M Bonetti; G B Frisoni
Journal:  J Neurol       Date:  2007-11-09       Impact factor: 4.849

10.  Identification of mild cognitive impairment in ACTIVE: algorithmic classification and stability.

Authors:  Sarah E Cook; Michael Marsiske; Kelsey R Thomas; Frederick W Unverzagt; Virginia G Wadley; Jessica B S Langbaum; Michael Crowe
Journal:  J Int Neuropsychol Soc       Date:  2012-10-25       Impact factor: 2.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.